One of thee top-rated benefits DIA member receive, TIRS advances health care product discovery development,regulation, and use through the publication of peer-reviewed articles and commentaries across the spectrum of converting biomedical science into practical solutions to advance human health.

Explore TIRS

Gregory Daniel

Editor-in-Chief

  
Gregory Daniel, PhD, MPH is the Deputy Director of the Duke-Robert J. Margolis, MD Center for Health Policy and a Clinical Professor in Duke's Fuqua School of Business. He directs the DC-based office of the Center leading its pharmaceutical and medical device policy portfolio, and is also an Adjunct Associate Professor at the UNC Eshelman School of Pharmacy. Dr. Daniel’s research expertise includes RWE development utilizing electronic health data in the areas of health outcomes and pharmacoeconomics, comparative effectiveness, and drug safety and pharmacoepidemiology. He received a PhD in pharmaceutical economics, policy and outcomes from the University of Arizona, and an MPH, MS, and BS in Pharmacy all from The Ohio State University.
Editorial Board
  • Theresa Allio


    Advanced Accelerator Applications
  • Christopher P. Austin


    Director, National Center for Advancing Translational Sciences, National Institutes of Health (NIH)
  • Josephine Babiarz


    Associate Professor , MCPHS University
  • Paul A. Bleicher


    Chief Executive Officer , OptumLabs
  • Leona Blustein


    Regional Medical Advisor, Arena Pharmaceuticals
  • David R. Bristol


    President, Statistical Consulting Services, Inc.
  • Joseph Cappelleri


    Executive Director of Biostatistics, Pfizer Inc
  • Andrzej Czarnecki


    Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety, Eli Lilly and Company
  • Richard O. Day

    Associate Editor
    Professor of Clinical Pharmacology; University of New South Wales, Medicine, St. Vincent's Hospital
  • Lode Dewulf


    Chief Patient Officer, Servier
  • Joseph A DiMasi


    Director, Economic Analysis and Research Associate Professor , Tufts Center for the Study of Drug Development
  • Rafe Donahue


    Senior Director, Statistics, Wright Medical
  • Sara Doshi


    Director, Medical Information Strategy and Capabilities, GMI, Eli Lilly and Company
  • Todd Durham


    Durham Statistical Consulting LLC
  • Ron D. Fitzmartin


    Sr. Informatics Advisor, FDA
  • Erick Gaussens


    ProductLife Group
  • Barbara Gladson


    Director of Biopharma Initiative; Interim Chair, Health Informatics, Rutgers School of Health Professions
  • Alan M. Hochberg


    Scientific Enablement Leader, F. Hoffmann-La Roche Ltd.
  • Stuart Horowitz


    President, Institutions & Institutional Services, WCG
  • Lisa Kammerman

    Associate Editor
    Regulatory Statistics and PRO Consultant, Kammerman Consulting, LLC
  • Mitchell W. Krucoff


    Professor of Medicine/Cardiology, Duke University
  • Gracie Lieberman

    Associate Editor
    Director Regulatory Policy, Genentech, A Member of the Roche Group
  • Craig Lipset


    Head of Clinical Innovation, Global Product Development, Pfizer Inc.
  • Wendy Louise Lipworth


    Senior Research Fellow, Centre for Values, Ethics and the Law in Medicine, University of Sydney
  • Christopher Paul Milne


    Director of Research and Research Associate Professor, Tufts Center for the Study of Drug Development
  • Shunsuke Ono


    Associate Professor, Laboratory of Pharmaceutical Regulatory Science, The University of Tokyo
  • Minsoo Park


    KCGI
  • Monika M. Pietrek


    Managing Director and Senior Consultant, Pietrek Associates GmbH
  • Peter J. Pitts


    President, Center for Medicine in the Public Interest
  • Ronald Portman


    Executive Director, Pediatric Therapeutic Area , Novartis Pharmaceuticals Corporation
  • Daniel S Reshef


    Safety Science Leader, Hoffman-La Roche, Inc.
  • Anne Rowzee

    Associate Editor
    Science Policy Analyst, FDA
  • Ramses F Sadek


    Professor of Biostatistics & Director of CRC BiostatisticsCore, Georgia Cancer Center at Augusta University
  • Jonathan Seltzer


    President and Chief Executive Officer, ACI Clinical
  • Mitchell Seymour


    Principal/Founder; Lead, Regulatory Operations, R&D Advisors, LLC; University of Michigan
  • R.William Soller


    President, Biomedical Regulatory Consulting
  • Amy Sun


    Senior Director, Sanofi-Aventis
  • Tetsuya Tanimoto


    Reviewer, Office of Biologics I, Pharmaceuticals and Medical Devices Agency (PMDA)
  • Rick Turner

    Editor Emeritus
    Expert Consultant, DRT Strategies, Inc.
  • Richard Zink

    Associate Editor
    Senior Director, Data Management and Statistics, TARGET Pharmasolutions Inc